{"word_count": 114, "character_count": 870}
Auteurs : Juntaro Arai, Nikkei staff writerProduction : NikkeiDiffusion : site de Nikkei Asian ReviewDate : 22 juillet 2020Cheap anti-inflammatory wins fast-track approval after slashing mortality rates in UK hospital trialTOKYO -- The Japanese health ministry has authorized the anti-inflammatory drug dexamethasone to treat severe cases of COVID-19 after the inexpensive steroid lowered fatalities by roughly a third in a British trial, marking the second time a candidate has won fast-track approval.Source : Juntaro Arai, « Japan greenlights dexamethasone as second coronavirus treatment », Nikkei Asian Review, 22/07/2020. URL : https://asia.nikkei.com/Spotlight/Coronavirus/Japan-greenlights-dexamethasone-as-second-coronavirus-treatment (consulté le 22/07/2020)Photo « à la une » : A pharmacist holds an ampule of dexamethasone at a hospital in Belgium. © Reuters